Furosemide-d5 (CAS 1189482-35-6)
See product citations (1)
QUICK LINKS
Furosemide-d5 is a deuterium-labeled analog of furosemide utilized predominantly in analytical chemistry for its stable isotopic label that facilitates accurate measurement in mass spectrometry. Employed as an internal standard, it allows for precise tracking and quantification of furosemide in biological matrices by providing a distinguishable mass difference that aids in the elimination of background noise and interference. In research focused on the elucidation of chemical metabolism and disposition, furosemide-d5 serves as a tool in the investigation of furosemide′s chemical kinetics. It is also instrumental in environmental studies that monitor the presence and behavior of furosemide in water systems, aiding in the assessment of its ecological impact. Additionally, furosemide-d5 is used in the development and refinement of analytical methods, which are essential for advancing scientific understanding of furosemide′s interactions and stability under various experimental conditions.
Furosemide-d5 (CAS 1189482-35-6) References
- Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses. | Dirikolu, L., et al. 2003. Vet Ther. 4: 350-63. PMID: 15136977
- Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS. | Murray, GJ. and Danaceau, JP. 2009. J Chromatogr B Analyt Technol Biomed Life Sci. 877: 3857-64. PMID: 19837636
- The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail. | Ebner, T., et al. 2015. J Pharm Sci. 104: 3220-8. PMID: 25981193
- Quantification of furosemide in camel plasma by high resolution mass spectrometry, application on pharmacokinetics. | Wasfi, IA., et al. 2017. Biomed Chromatogr. 31: PMID: 27859445
- Removal characteristics of pharmaceuticals and personal care products: Comparison between membrane bioreactor and various biological treatment processes. | Park, J., et al. 2017. Chemosphere. 179: 347-358. PMID: 28384602
- Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys. | Shen, H., et al. 2018. Drug Metab Dispos. 46: 178-188. PMID: 29162614
- Ammonia Monooxygenase-Mediated Cometabolic Biotransformation and Hydroxylamine-Mediated Abiotic Transformation of Micropollutants in an AOB/NOB Coculture. | Yu, Y., et al. 2018. Environ Sci Technol. 52: 9196-9205. PMID: 30004677
- Determination of drugs in exhumed liver and brain tissue after over 9 years of burial by liquid chromatography-tandem mass spectrometry-Part 1: Cardiovascular drugs. | Bolte, K., et al. 2021. Drug Test Anal. 13: 595-603. PMID: 33017092
- Identification of furosemide in hair in a post-mortem case by UHPLC-MS/MS with guidance on interpretation. | Gheddar, L., et al. 2021. J Forensic Sci. 66: 272-277. PMID: 33027535
- Development of a furosemide-containing expandable system for gastric retention. | Neumann, M., et al. 2021. J Control Release. 338: 105-118. PMID: 34416321
- Development, validation, and implementation of an UHPLC-MS/MS method for the quantitation of furosemide in infant urine samples. | Vedar, C., et al. 2022. Biomed Chromatogr. 36: e5262. PMID: 34648199
- A whole blood microsampling furosemide assay: development, validation and use in a pediatric pharmacokinetic study. | Bamat, NA., et al. 2022. Bioanalysis. 14: 1025-1038. PMID: 36165919
- The removal of micropollutants from treated effluent by batch-operated pilot-scale constructed wetlands. | Lei, Y., et al. 2023. Water Res. 230: 119494. PMID: 36571965
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Furosemide-d5, 1 mg | sc-218550 | 1 mg | $530.00 | |||
Furosemide-d5, 10 mg | sc-218550A | 10 mg | $2305.00 |